메뉴 건너뛰기




Volumn 39, Issue 11, 2009, Pages 1711-1720

Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells

Author keywords

Basophils; Ige receptor; Mast cells; Mastocytosis; Midostaurin

Indexed keywords

CD63 ANTIGEN; IMATINIB; IMMUNOGLOBULIN E; MIDOSTAURIN; NILOTINIB; PROTEIN KINASE C; STEM CELL FACTOR;

EID: 70350333277     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2009.03353.x     Document Type: Article
Times cited : (63)

References (35)
  • 1
    • 0041411106 scopus 로고    scopus 로고
    • Diagnosis and treatment of systemic mastocytosis: State of the art
    • Valent P, Akin C, Sperr WR et al. Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 2003 122 : 695 717.
    • (2003) Br J Haematol , vol.122 , pp. 695-717
    • Valent, P.1    Akin, C.2    Sperr, W.R.3
  • 2
    • 1542329011 scopus 로고    scopus 로고
    • Systemic mastocytosis
    • Akin C, Metcalfe DD. Systemic mastocytosis. Annu Rev Med 2004 55 : 419 432.
    • (2004) Annu Rev Med , vol.55 , pp. 419-432
    • Akin, C.1    Metcalfe, D.D.2
  • 4
    • 0036207693 scopus 로고    scopus 로고
    • Histopathological and immunohistochemical aspects of mastocytosis
    • Horny HP, Valent P. Histopathological and immunohistochemical aspects of mastocytosis. Int Arch Allergy Immunol 2002 127 : 115 117.
    • (2002) Int Arch Allergy Immunol , vol.127 , pp. 115-117
    • Horny, H.P.1    Valent, P.2
  • 6
    • 0028856070 scopus 로고
    • Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
    • Nagata H, Worobec AS, Oh CK et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995 92 : 10560 10564.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 10560-10564
    • Nagata, H.1    Worobec, A.S.2    Oh, C.K.3
  • 7
    • 0009013631 scopus 로고    scopus 로고
    • Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
    • Longley BJ, Tyrrell L, Lu SZ et al. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996 12 : 312 314.
    • (1996) Nat Genet , vol.12 , pp. 312-314
    • Longley, B.J.1    Tyrrell, L.2    Lu, S.Z.3
  • 8
    • 13044305857 scopus 로고    scopus 로고
    • Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis
    • Longley BJ, Metcalfe DD, Tharp M et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999 96 : 1609 1614.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 1609-1614
    • Longley, B.J.1    Metcalfe, D.D.2    Tharp, M.3
  • 9
    • 0035010149 scopus 로고    scopus 로고
    • Mutation analysis of c-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis
    • Fritsche-Polanz R, Jordan JH, Feix A et al. Mutation analysis of c-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br J Haematol 2001 113 : 357 364.
    • (2001) Br J Haematol , vol.113 , pp. 357-364
    • Fritsche-Polanz, R.1    Jordan, J.H.2    Feix, A.3
  • 10
    • 0036207241 scopus 로고    scopus 로고
    • Kit and c-kit mutations in mastocytosis: A short overview with special reference to novel molecular and diagnostic concepts
    • Féger F, Ribadeau Dumas A, Leriche L, Valent P, Arock M. Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts. Int Arch Allergy Immunol 2002 127 : 110 114.
    • (2002) Int Arch Allergy Immunol , vol.127 , pp. 110-114
    • Féger, F.1    Ribadeau Dumas, A.2    Leriche, L.3    Valent, P.4    Arock, M.5
  • 11
    • 0345772088 scopus 로고    scopus 로고
    • Aggressive systemic mastocytosis and related mast cell disorders: Current treatment options and proposed response criteria
    • Valent P, Akin C, Sperr WR et al. Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 2003 27 : 635 641.
    • (2003) Leuk Res , vol.27 , pp. 635-641
    • Valent, P.1    Akin, C.2    Sperr, W.R.3
  • 12
    • 37749039528 scopus 로고    scopus 로고
    • Anaphylaxis in patients with mastocytosis: A study on history, clinical features and risk factors in 120 patients
    • Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008 63 : 226 232.
    • (2008) Allergy , vol.63 , pp. 226-232
    • Brockow, K.1    Jofer, C.2    Behrendt, H.3    Ring, J.4
  • 13
    • 4944253841 scopus 로고    scopus 로고
    • On the way to targeted therapy of mast cell neoplasms: Identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts
    • Valent P, Ghannadan M, Akin C et al. On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts. Eur J Clin Invest 2004 34 : 41 52.
    • (2004) Eur J Clin Invest , vol.34 , pp. 41-52
    • Valent, P.1    Ghannadan, M.2    Akin, C.3
  • 14
    • 19944434116 scopus 로고    scopus 로고
    • Mastocytosis: Pathology, genetics, and current options for therapy
    • Valent P, Akin C, Sperr WR et al. Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma 2005 46 : 35 48.
    • (2005) Leuk Lymphoma , vol.46 , pp. 35-48
    • Valent, P.1    Akin, C.2    Sperr, W.R.3
  • 15
    • 38549127753 scopus 로고    scopus 로고
    • How we diagnose and treat WHO-defined systemic mastocytosis in adults
    • Tefferi A, Verstovsek S, Pardanani A. How we diagnose and treat WHO-defined systemic mastocytosis in adults. Haematologica 2008 93 : 6 9.
    • (2008) Haematologica , vol.93 , pp. 6-9
    • Tefferi, A.1    Verstovsek, S.2    Pardanani, A.3
  • 16
    • 27144506215 scopus 로고    scopus 로고
    • Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
    • Gotlib J, Berubé C, Growney JD et al. Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 2005 106 : 2865 2870.
    • (2005) Blood , vol.106 , pp. 2865-2870
    • Gotlib, J.1    Berubé, C.2    Growney, J.D.3
  • 17
    • 30444446680 scopus 로고    scopus 로고
    • PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: Comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects
    • Gleixner KV, Mayerhofer M, Aichberger KJ et al. PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects. Blood 2006 107 : 752 759.
    • (2006) Blood , vol.107 , pp. 752-759
    • Gleixner, K.V.1    Mayerhofer, M.2    Aichberger, K.J.3
  • 18
    • 33645687784 scopus 로고    scopus 로고
    • Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis
    • Shah NP, Lee FY, Luo R, Jiang Y, Donker M, Akin C. Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis. Blood 2006 108 : 286 291.
    • (2006) Blood , vol.108 , pp. 286-291
    • Shah, N.P.1    Lee, F.Y.2    Luo, R.3    Jiang, Y.4    Donker, M.5    Akin, C.6
  • 19
    • 36349020293 scopus 로고    scopus 로고
    • Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT
    • Gleixner KV, Mayerhofer M, Sonneck K et al. Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT. Haematologica 2007 92 : 1451 1459.
    • (2007) Haematologica , vol.92 , pp. 1451-1459
    • Gleixner, K.V.1    Mayerhofer, M.2    Sonneck, K.3
  • 20
    • 39049130408 scopus 로고    scopus 로고
    • STI571 (Glivec(R)) affects histamine release and intracellular pH after alkalinisation in HMC-1(560, 816)
    • Löber K, Alfonso A, Escribano L, Botana LM. STI571 (Glivec(R)) affects histamine release and intracellular pH after alkalinisation in HMC-1(560, 816). J Cell Biochem 2008 103 : 865 876.
    • (2008) J Cell Biochem , vol.103 , pp. 865-876
    • Löber, K.1    Alfonso, A.2    Escribano, L.3    Botana, L.M.4
  • 21
    • 42449139172 scopus 로고    scopus 로고
    • The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils
    • Kneidinger M, Schmidt U, Rix U et al. The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Blood 2008 111 : 3097 3107.
    • (2008) Blood , vol.111 , pp. 3097-3107
    • Kneidinger, M.1    Schmidt, U.2    Rix, U.3
  • 22
    • 18844478996 scopus 로고    scopus 로고
    • PKC412 - A protein kinase inhibitor with a broad therapeutic potential
    • Fabbro D, Ruetz S, Bodis S et al. PKC412 - a protein kinase inhibitor with a broad therapeutic potential. Anticancer Drug Des 2000 15 : 17 28.
    • (2000) Anticancer Drug des , vol.15 , pp. 17-28
    • Fabbro, D.1    Ruetz, S.2    Bodis, S.3
  • 23
    • 13844251975 scopus 로고    scopus 로고
    • Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
    • Weisberg E, Manley PW, Breitenstein W et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell 2005 7 : 129 141.
    • (2005) Cancer Cell , vol.7 , pp. 129-141
    • Weisberg, E.1    Manley, P.W.2    Breitenstein, W.3
  • 25
    • 33947420879 scopus 로고    scopus 로고
    • Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab
    • Mirkina I, Schweighoffer T, Kricek F. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab. Immunol Lett 2007 109 : 120 128.
    • (2007) Immunol Lett , vol.109 , pp. 120-128
    • Mirkina, I.1    Schweighoffer, T.2    Kricek, F.3
  • 26
    • 0023950976 scopus 로고
    • Establishment of an immature mast cell line from a patient with mast cell leukemia
    • Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988 12 : 345 355.
    • (1988) Leuk Res , vol.12 , pp. 345-355
    • Butterfield, J.H.1    Weiler, D.2    Dewald, G.3    Gleich, G.J.4
  • 27
    • 0026355821 scopus 로고
    • IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells
    • Sillaber C, Strobl H, Bevec D et al. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol 1991 147 : 4224 4228.
    • (1991) J Immunol , vol.147 , pp. 4224-4228
    • Sillaber, C.1    Strobl, H.2    Bevec, D.3
  • 28
    • 33644900475 scopus 로고    scopus 로고
    • Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells
    • Krauth MT, Majlesi Y, Sonneck K et al. Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells. Allergy 2006 61 : 281 288.
    • (2006) Allergy , vol.61 , pp. 281-288
    • Krauth, M.T.1    Majlesi, Y.2    Sonneck, K.3
  • 29
    • 0036968257 scopus 로고    scopus 로고
    • Recombinant allergens promote expression of CD203c on basophils in sensitized individuals
    • Hauswirth AW, Natter S, Ghannadan M et al. Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J Allergy Clin Immunol 2002 110 : 102 109.
    • (2002) J Allergy Clin Immunol , vol.110 , pp. 102-109
    • Hauswirth, A.W.1    Natter, S.2    Ghannadan, M.3
  • 30
    • 0033604543 scopus 로고    scopus 로고
    • Signaling through the high-affinity IgE receptor Fc-epsilon RI
    • Turner H, Kinet JP. Signaling through the high-affinity IgE receptor Fc-epsilon RI. Nature 1999 402 : 24 30.
    • (1999) Nature , vol.402 , pp. 24-30
    • Turner, H.1    Kinet, J.P.2
  • 31
    • 0034713675 scopus 로고    scopus 로고
    • Immunologically mediated signaling in basophils and mast cells: Finding therapeutic targets for allergic diseases in the human Fc-epsilon RI signaling pathway
    • Oliver JM, Kepley CL, Ortega E, Wilson BS. Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human Fc-epsilon RI signaling pathway. Immunopharmacology 2000 48 : 269 281.
    • (2000) Immunopharmacology , vol.48 , pp. 269-281
    • Oliver, J.M.1    Kepley, C.L.2    Ortega, E.3    Wilson, B.S.4
  • 32
    • 37049014938 scopus 로고    scopus 로고
    • Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets
    • Rix U, Hantschel O, Dürnberger G et al. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood 2007 110 : 4055 4063.
    • (2007) Blood , vol.110 , pp. 4055-4063
    • Rix, U.1    Hantschel, O.2    Dürnberger, G.3
  • 33
    • 1842830011 scopus 로고    scopus 로고
    • The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis
    • Bühring HJ, Streble A, Valent P. The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis. Int Arch Allergy Immunol 2004 133 : 317 329.
    • (2004) Int Arch Allergy Immunol , vol.133 , pp. 317-329
    • Bühring, H.J.1    Streble, A.2    Valent, P.3
  • 34
    • 27344453965 scopus 로고    scopus 로고
    • Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation
    • Hennersdorf F, Florian S, Jakob A et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. Cell Res 2005 15 : 325 335.
    • (2005) Cell Res , vol.15 , pp. 325-335
    • Hennersdorf, F.1    Florian, S.2    Jakob, A.3
  • 35
    • 41849098106 scopus 로고    scopus 로고
    • Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients
    • Sonneck K, Baumgartner C, Rebuzzi L et al. Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients. Int J Immunopathol Pharmacol 2008 21 : 11 21.
    • (2008) Int J Immunopathol Pharmacol , vol.21 , pp. 11-21
    • Sonneck, K.1    Baumgartner, C.2    Rebuzzi, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.